Exact Sciences (Group)

https://www.exactsciences.com

LinkedIn: https://linkedin.com/company/48835

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than 20 years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies will help enable detection of colorectal cancer so that more people can be effectively treated. EXACT Sciences is based in Marlborough, Mass. PreGen-Plus(TM), the non-invasive colorectal cancer screening testing service offered by LabCorp, has not been approved or cleared by the Food & Drug Administration. *

	Start	1995-02-10 established_pre
	End	1996-12-11 renamed
	Industry	diagnostics (medical/biological)
	Person	Conroy, Kevin T. (Exact Sciences 200904– CEO before Third Wave 200407– CEO since 12/05 before GE Healthcare)

	Street	441 Charmany Drive
	City	53719 Madison, WI
		Address record changed: 2024-01-05

Basic data	Employees	B: 11 to 50 (2006-12-31)
	Currency	USD
	Annual sales	1,798,000 (revenue, total, consolidated (2007) 2007-12-31)
	Profit	-11,959,000 (2007-12-31)
	Cash	4,486,000 (2007-12-31)

		* Document for »About Section«:

		Record changed: 2023-07-10